Similar articles

• Ketamine-fentanyl-midazolam infusion for the control of symptoms in terminal life care.

  Berger JM, Ryan A, Vadivelu N, Merriam P, Rever L, Harrison P. Berger JM, et al. Am J Hosp Palliat Care. 2000 Mar-Apr;17(2):127-34. doi: 10.1177/104990910001700213. Am J Hosp Palliat Care. 2000. PMID: 11406957
• Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial.

  Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Sener S, et al. Ann Emerg Med. 2011 Feb;57(2):109-114.e2. doi: 10.1016/j.annemergmed.2010.09.010. Ann Emerg Med. 2011. PMID: 20970888 Clinical Trial.
• Pain, fentanyl consumption, and delirium in adolescents after scoliosis surgery: dexmedetomidine vs midazolam.

  Aydogan MS, Korkmaz MF, Ozgül U, Erdogan MA, Yucel A, Karaman A, Togal T, Durmus M, Colak C. Aydogan MS, et al. Paediatr Anaesth. 2013 May;23(5):446-52. doi: 10.1111/pan.12128. Epub 2013 Feb 28. Paediatr Anaesth. 2013. PMID: 23448434 Clinical Trial.
• [Sedation in the terminal phase of life].

  Verhagen EH, Eliel MR, de Graeff A, Teunissen SC. Verhagen EH, et al. Ned Tijdschr Geneeskd. 1999 Dec 25;143(52):2601-3. Ned Tijdschr Geneeskd. 1999. PMID: 10633803 Review. Dutch.
• Palliative sedation: A safety net for the relief of refractory and intolerable symptoms at the end of life.

  Patel C, Kleinig P, Bakker M, Tait P. Patel C, et al. Aust J Gen Pract. 2019 Dec;48(12):838-845. doi: 10.31128/AJGP-05-19-4938. Aust J Gen Pract. 2019. PMID: 31774984 Review.